NO20060743L - Nasal farmasoytisk sammensetning av piribedil - Google Patents

Nasal farmasoytisk sammensetning av piribedil

Info

Publication number
NO20060743L
NO20060743L NO20060743A NO20060743A NO20060743L NO 20060743 L NO20060743 L NO 20060743L NO 20060743 A NO20060743 A NO 20060743A NO 20060743 A NO20060743 A NO 20060743A NO 20060743 L NO20060743 L NO 20060743L
Authority
NO
Norway
Prior art keywords
piribedil
pharmaceutical composition
nasal pharmaceutical
nasal
powder
Prior art date
Application number
NO20060743A
Other languages
English (en)
Other versions
NO332776B1 (no
Inventor
Herve Rolland
Patrick Wutrich
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20060743L publication Critical patent/NO20060743L/no
Publication of NO332776B1 publication Critical patent/NO332776B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Den foreliggende oppfirmelse vedrører en nasal farmasøytisk sanmiensetning av piribedil i form av en løsning eller et pulver.
NO20060743A 2003-07-17 2006-02-16 Nasal farmasoytisk sammensetning av piribedil NO332776B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0308712A FR2857594B1 (fr) 2003-07-17 2003-07-17 Composition pharmaceutique pour l'administration par voie nasale de piribedil
PCT/FR2004/001867 WO2005009442A1 (fr) 2003-07-17 2004-07-16 Composition pharmaceutique pour l’administration par voie nasale de piribedil

Publications (2)

Publication Number Publication Date
NO20060743L true NO20060743L (no) 2006-02-16
NO332776B1 NO332776B1 (no) 2013-01-14

Family

ID=33548200

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060743A NO332776B1 (no) 2003-07-17 2006-02-16 Nasal farmasoytisk sammensetning av piribedil

Country Status (29)

Country Link
US (1) US20060204449A1 (no)
EP (1) EP1653963B1 (no)
JP (1) JP2007516947A (no)
KR (1) KR100807480B1 (no)
CN (1) CN100540004C (no)
AR (1) AR046808A1 (no)
AT (1) ATE349213T1 (no)
AU (1) AU2004258714A1 (no)
BR (1) BRPI0412681A (no)
CA (1) CA2532631C (no)
CY (1) CY1106013T1 (no)
DE (1) DE602004003955T2 (no)
DK (1) DK1653963T3 (no)
EA (1) EA011041B1 (no)
ES (1) ES2279435T3 (no)
FR (1) FR2857594B1 (no)
GE (1) GEP20074259B (no)
HR (1) HRP20070081T5 (no)
MA (1) MA27864A1 (no)
MX (1) MXPA06000641A (no)
MY (1) MY137747A (no)
NO (1) NO332776B1 (no)
NZ (1) NZ544460A (no)
PL (1) PL1653963T3 (no)
PT (1) PT1653963E (no)
SI (1) SI1653963T1 (no)
UA (1) UA85193C2 (no)
WO (1) WO2005009442A1 (no)
ZA (1) ZA200600240B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8969417B2 (en) * 2008-06-06 2015-03-03 Pharmatwob Ltd. Pharmaceutical compositions for treatment of Parkinsons disease
WO2014141280A1 (en) * 2013-03-13 2014-09-18 Abital Pharma Pipelines Ltd. Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's disease
IT201800005117A1 (it) 2018-05-07 2019-11-07 Acqua irradiata con energie elettromagnetiche per uso terapeutico

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1007402A5 (nl) * 1993-03-26 1995-06-06 Adir Nasale farmaceutische preparaten met progestagene stof.
ATE290864T1 (de) * 1993-03-26 2005-04-15 Franciscus Wilhelmus He Merkus Pharmazeutische zusammensetzungen zur intranasalen verabreichung von dihydroergotamin
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
FR2710268B1 (fr) * 1993-09-22 1995-10-20 Adir Utilisation de beta-cyclodextrines partiellement méthylées comme promoteurs d'absorption dans la préparation de compositions pharmaceutiques pour l'administration transcutanée de principes actifs.
FR2742989B1 (fr) * 1995-12-29 1998-01-23 Adir Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs
JP2001518923A (ja) * 1997-03-26 2001-10-16 ダブリュ エイチ エム マーカス，フランシスカス 鼻腔用メラトニン組成物
EP0900567A3 (en) * 1997-09-05 2001-05-02 Pfizer Products Inc. Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
US20020002175A1 (en) * 2000-09-19 2002-01-03 Charanjit Behl Nasal delivery of apomorphine in combination with glycol derivatives
US20040028613A1 (en) * 2001-06-25 2004-02-12 Nastech Pharmaceutical Company Inc Dopamine agonist formulations for enhanced central nervous system delivery
FR2827516B1 (fr) * 2001-07-19 2003-09-19 Servier Lab Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone

Also Published As

Publication number Publication date
AU2004258714A1 (en) 2005-02-03
PT1653963E (pt) 2007-02-28
ES2279435T3 (es) 2007-08-16
ATE349213T1 (de) 2007-01-15
NZ544460A (en) 2008-04-30
JP2007516947A (ja) 2007-06-28
FR2857594B1 (fr) 2005-09-16
WO2005009442A1 (fr) 2005-02-03
CN1819828A (zh) 2006-08-16
KR20060031689A (ko) 2006-04-12
HK1094153A1 (zh) 2007-03-23
CA2532631A1 (fr) 2005-02-03
AR046808A1 (es) 2005-12-28
MXPA06000641A (es) 2006-03-30
US20060204449A1 (en) 2006-09-14
EA200600172A1 (ru) 2006-06-30
CA2532631C (fr) 2011-01-04
SI1653963T1 (sl) 2007-04-30
KR100807480B1 (ko) 2008-02-25
MA27864A1 (fr) 2006-04-03
DE602004003955D1 (de) 2007-02-08
BRPI0412681A (pt) 2006-10-03
CN100540004C (zh) 2009-09-16
UA85193C2 (ru) 2009-01-12
HRP20070081T5 (hr) 2007-08-31
FR2857594A1 (fr) 2005-01-21
DK1653963T3 (da) 2007-04-10
EP1653963B1 (fr) 2006-12-27
ZA200600240B (en) 2007-03-28
PL1653963T3 (pl) 2007-02-28
GEP20074259B (en) 2007-12-10
EA011041B1 (ru) 2008-12-30
CY1106013T1 (el) 2011-04-06
HRP20070081T3 (hr) 2007-04-30
NO332776B1 (no) 2013-01-14
EP1653963A1 (fr) 2006-05-10
MY137747A (en) 2009-03-31
DE602004003955T2 (de) 2007-12-06

Similar Documents

Publication Publication Date Title
ECSP067110A (es) Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
WO2005115406A3 (en) 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
ECSP10010265A (es) Sales farmaceuticamente aceptables de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8 dihidro-9h-purin-9-il)propil](3-morfolin-4 ilpropil)amino]metil}fenil)
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
EA017764B8 (ru) Фармацевтическая композиция, способ ее получения и способ лечения вирусных заболеваний с ее использованием
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
MY142329A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents.
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
TNSN04206A1 (en) Novel perindopril salt and pharmaceutical compositions containing same
HRP20050386A2 (en) Daily melatonin dosing units
UY31403A1 (es) "derivados novedosos de ({((3-metilfenil)-2h-tetrazol-5-il)-etoxi} -4h-1,2,4-triazol-3-il), composiciones farmacéuticas conteniendolos y uso médico de los mismos".
MXPA03010158A (es) Sulfonamidas.
MEP34308A (en) Oral formulations of cladribine
NO20062824L (no) 1,3-Difenylprop-2-en-1-on-avledete forbindelser, fremgangsmater for fremstilling derav, samt anvendelse av samme
NO20060743L (no) Nasal farmasoytisk sammensetning av piribedil
DE602007010038D1 (de) Pyrimidylderivate als proteinkinaseinhibitoren
BR0208221A (pt) Combinação de uma taxano e uma cinase dependente de ciclina
CR10098A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
WO2004043366A3 (en) Sulfonamides
NO20085267L (no) Derivater av 2-alkoksy -3,4,5-trihydroksy-alkyl amider, fremstilling og anvendelse derav, samt sammensetninger inneholdende samme
WO2004043369A3 (en) Sulfonamides
WO2004043368A3 (en) Sulfonamides

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees